Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
DiLullo, Sherry L.
and
Martin-Iverson, Mathew T.
1992.
Calcium channel blockade interacts with a neuroleptic to attenuate the conditioning of amphetamine's behavioral effects in the rat.
Biological Psychiatry,
Vol. 31,
Issue. 11,
p.
1143.
Pucilowski, Olgierd
1992.
Psychopharmacological properties of calcium channel inhibitors.
Psychopharmacology,
Vol. 109,
Issue. 1-2,
p.
12.
Beauchamp, G.
Lavoie, P. -A.
and
Elie, R.
1993.
Effect of some stereoisomeric tricyclic antidepressants on45Ca uptake in synaptosomes from rat hippocampus.
Psychopharmacology,
Vol. 110,
Issue. 1-2,
p.
133.
Dassylva, Benoit
1993.
Verapamil May Cause Depression.
The Canadian Journal of Psychiatry,
Vol. 38,
Issue. 4,
p.
299.
Berk, Michael
and
Kirchmann, Nicola Helen
1995.
Enhanced blockade of 45Ca2+ uptake into platelets in manic patients with bipolar affective disorder with flunarazine and verapamil.
Human Psychopharmacology: Clinical and Experimental,
Vol. 10,
Issue. 4,
p.
299.
Rothschild, Anthony J.
1996.
MANAGEMENT OF PSYCHOTIC, TREATMENT-RESISTANT DEPRESSION.
Psychiatric Clinics of North America,
Vol. 19,
Issue. 2,
p.
237.
Pucilowski, Olgierd
1997.
Antidepressants.
p.
81.
Hollister, Leo E
and
Trevino, Enrique Sergio Garza
1999.
Calcium Channel Blockers in Psychiatric Disorders: A Review of the Literature.
The Canadian Journal of Psychiatry,
Vol. 44,
Issue. 7,
p.
658.
Levy, Naomi A
and
Janicak, Philip G
2000.
Calcium channel antagonists for the treatment of bipolar disorder.
Bipolar Disorders,
Vol. 2,
Issue. 2,
p.
108.
KELLER, SETH
and
FRISHMAN, WILLIAM H.
2003.
Neuropsychiatric Effects of Cardiovascular Drug Therapy.
Cardiology in Review,
Vol. 11,
Issue. 2,
p.
73.
Kabir, Zeeba D.
Martínez-Rivera, Arlene
and
Rajadhyaksha, Anjali M.
2017.
From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.
Neurotherapeutics,
Vol. 14,
Issue. 3,
p.
588.
Dubovsky, Steven L.
2019.
Applications of calcium channel blockers in psychiatry: pharmacokinetic and pharmacodynamic aspects of treatment of bipolar disorder.
Expert Opinion on Drug Metabolism & Toxicology,
Vol. 15,
Issue. 1,
p.
35.
eLetters
No eLetters have been published for this article.